Role of phytocompounds as the potential anti-viral agent: an overview

被引:0
|
作者
Swati Sucharita Mohanty
Chita Ranjan Sahoo
Sudhir Kumar Paidesetty
Rabindra Nath Padhy
机构
[1] IMS & Sum Hospital,Department of Medical Oncology
[2] Siksha ‘O’ Anusandhan Deemed to Be University,Central Research Laboratory
[3] IMS & Sum Hospital,Department of Health Research, Ministry of Health & Family Welfare, Govt. of India
[4] Siksha ‘O’ Anusandhan Deemed to Be University,Department of Medicinal Chemistry, School of Pharmaceutical Science
[5] ICMR-Regional Medical Research Centre,undefined
[6] Siksha ‘O’ Anusandhan Deemed to Be University,undefined
关键词
Phytochemicals; Natural product; COVID-19; Antiviral; Viral infection disease; SAR studies;
D O I
暂无
中图分类号
学科分类号
摘要
Viral diseases are the most notorious infective agent(s) causing morbidity and mortality in every nook and corner for ages; viruses are active in host cells, and specific anti-virus medicines’ developments remain uncanny. In this century of the biological era, human viruses act predominantly as versatile spreaders. The infection of the present COVID-19 virus is up in the air; blithely, the integument of medicinal chemistry approaches, particularly bioactive derived phytocompounds could be helpful to control those human viruses, recognized in the last 100 years. Indeed, natural products are being used for various therapeutic purposes. The major bioactive phytocompounds are chemically containing coumarin, thiosulfonate, steroid, polysaccharide, tannin, lignin, proanthocyanidin, terpene, quinone, saponin, flavonoid, alkaloid, and polyphenol, that are documented for inhibitory action against several viral infections. Mostly, about 20–30% of plants from tropical or temperate regions are known to have some antiviral activity. This comprehensive analysis of bioactive-derived phytocompounds would represent a significant impact and might be helpful for antiviral research and the current state of viral treatments.
引用
收藏
页码:2311 / 2329
页数:18
相关论文
共 50 条
  • [31] ANTI-VIRAL THERAPY
    不详
    SOUTH AFRICAN MEDICAL JOURNAL, 1980, 57 (12): : 429 - 430
  • [32] ANTI-VIRAL AGENTS
    CULLEN, GA
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1981, 74 (08) : 628 - 629
  • [33] ANTI-VIRAL AGENTS
    HERMANS, PE
    MAYO CLINIC PROCEEDINGS, 1977, 52 (11) : 683 - 686
  • [34] STUDIES ABOUT ANTI-VIRAL AGENT ADENINE-ARABINOSIDE-MONOPHOSPHATE
    WERNER, GT
    BOMER, H
    METZGER, E
    SAUER, O
    SCHNEIDER, H
    SCHUBERT, E
    TREUNER, J
    FORTSCHRITTE DER MEDIZIN, 1978, 96 (32) : 1589 - 1597
  • [35] Potential Role of Accessory Domains in Polyproteins Encoded by Retrotransposons in Anti-viral Defense of Host Cells
    Morozov, Sergey Y.
    Lezzhov, Alexander A.
    Lazareva, Ekaterina A.
    Erokhina, Tatiana N.
    Solovyev, Andrey G.
    FRONTIERS IN MICROBIOLOGY, 2019, 9
  • [36] Use of the anti-viral drug ribavirin as a radiosensitizing agent in nasopharyngeal carcinoma
    Huq, Sakibul
    Casaos, Joshua
    Serra, Riccardo
    Peters, Michael
    Xia, Yuanxuan
    Ding, Andy
    Ehresman, Jeffrey
    Kedda, Jayanidhi
    Morales, Manuel
    Gorelick, Noah
    Zhao, Tianna
    Ishida, Wataru
    Perdomo-Pantoja, Alexander
    Cecia, Arba
    Ji, Chenchen
    Suk, Ian
    Sidransky, David
    Brait, Mariana
    Brem, Henry
    Skuli, Nicolas
    Tyler, Betty
    CANCER RESEARCH, 2020, 80 (16)
  • [37] REPURPOSING OF THE ANTI-VIRAL DRUG RIBAVIRIN AS A POTENTIAL MENINGIOMA THERAPEUTIC
    Casaos, Joshua
    Perryman, Travis
    Harary, Maya
    Vitte, Jeremie
    Shah, Shilp
    Na, Brian
    Giovannini, Marco
    Everson, Richard
    NEURO-ONCOLOGY, 2024, 26
  • [38] PRELIMINARY STUDIES OF THE MODE OF ACTION OF ARILDONE, A NOVEL ANTI-VIRAL AGENT
    KUHRT, MF
    FANCHER, MJ
    JASTY, V
    PANCIC, F
    CAME, PE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (06) : 813 - 819
  • [39] α-glucosidase inhibitors as potential broad based anti-viral agents
    Mehta, A
    Zitzmann, N
    Rudd, PM
    Block, TM
    Dwek, RA
    FEBS LETTERS, 1998, 430 (1-2) : 17 - 22